financetom
Business
financetom
/
Business
/
Lowe's CEO Calls Out Near-Term Housing Market Challenges But Holds The Line On Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lowe's CEO Calls Out Near-Term Housing Market Challenges But Holds The Line On Outlook
May 26, 2025 11:41 AM

Lowe’s Companies, Inc. on Wednesday reported mixed results for the first quarter of fiscal 2025.

The company posted adjusted earnings of $2.92 per share, which beat the analyst consensus estimate of $2.89.

Revenue for the quarter was down 2% year over year at $20.93 billion, which missed the analyst consensus estimate of $20.94 billion.

Comparable sales fell 1.7%, with early-quarter weather headwinds partially offset by mid-single-digit growth in Pro and online sales.

Also Read: Lowe’s Lowdown? Analyst Sees Weaker Sales Than Consensus, Cites Weather Woes

Gross margin expanded 19 basis points to 33.4% while operating income declined to $2.49 billion from $2.65 billion last year. Operating margin narrowed by 50 basis points to 11.9%.

As of May 2, 2025, Lowe’s operated 1,750 stores, totaling approximately 195.3 million square feet of retail selling space.

“Despite near-term uncertainty and housing market headwinds, our team’s unwavering focus on exceptional customer service has elevated satisfaction scores and earned Lowe’s the No. 1 ranking in Customer Satisfaction among Home Improvement Retailers by J.D. Power,” said Marvin R. Ellison, Lowe’s chairman, president, and CEO.

“Strategic investments in technology, inviting store environments, and our dedicated associates continue to solidify our commitment to serving our customers and communities,” Ellison added.

The company reported operating cash flow of $3.38 billion for the quarter, down from $4.26 billion a year earlier.

The company reiterated its focus on disciplined capital allocation, highlighted by a $645 million dividend paid this quarter.

Lowe’s acknowledged tariffs as a potential risk factor but did not provide specific guidance on their impact.

Lowe’s forecasts 2025 EPS of $12.15–$12.40 versus the $12.23 consensus estimate. Total sales are projected between $83.5 billion and $84.5 billion, compared with analysts’ expectations of $84.31 billion.

Lowe’s expects an operating margin of 12.3% to 12.4% and plans to spend approximately $2.5 billion on capital expenditures.

Price Action: LOW shares are trading lower by 0.37% to $230.41 at last check Wednesday.

Read Next:

Home Depot Flags Tariff And Supply Chain Risks In Risk Statement But Does Not Revise Outlook

Image via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Invivyd Launches Public Stock Offering
Invivyd Launches Public Stock Offering
Nov 17, 2025
05:14 PM EST, 11/17/2025 (MT Newswires) -- Invivyd ( IVVD ) said Monday it has initiated an underwritten public stock offering, with all shares being sold by the company. The underwriters have a 30-day option to buy up to 15% additional shares at the offering price, excluding discounts and commissions, the company said. The offering's size and timing remain uncertain...
Roivant Sciences Insider Sold Shares Worth $37,939,112, According to a Recent SEC Filing
Roivant Sciences Insider Sold Shares Worth $37,939,112, According to a Recent SEC Filing
Nov 17, 2025
05:58 PM EST, 11/17/2025 (MT Newswires) -- Vivek Ramaswamy, 10% Owner, on November 13, 2025, sold 1,854,603 shares in Roivant Sciences ( ROIV ) for $37,939,112. Following the Form 4 filing with the SEC, Ramaswamy has control over a total of 47,011,613 common shares of the company, with 33,653,756 shares held directly and 13,357,857 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1635088/000163507525000005/xslF345X05/primary_doc.xml ...
Welsh Carson-backed Lumexa Imaging reveals narrower loss in US IPO filing
Welsh Carson-backed Lumexa Imaging reveals narrower loss in US IPO filing
Nov 17, 2025
Nov 17 (Reuters) - Lumexa reported a narrower loss for the first nine months of 2025, the Welsh, Carson, Anderson & Stowe-backed medical imaging firm revealed in its U.S. initial public offering paperwork on Monday, aiming to tap a gradually reopening new listings window. IPO activity in the U.S had recovered from tariff shocks to have its busiest autumn in...
AirSculpt Names Mike Doyle as Non-Executive Chairman
AirSculpt Names Mike Doyle as Non-Executive Chairman
Nov 17, 2025
05:59 PM EST, 11/17/2025 (MT Newswires) -- AirSculpt Technologies ( AIRS ) said late Monday it appointed Mike Doyle as non-executive chairman of its board. Doyle previously served as chief executive of Surgery Partners and founded MD Healthcare Partners, the company said. Shares of AirSculpt Technologies ( AIRS ) were up more than 1% in after-hours trading. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved